Semaglutide Safety Profile Without a Gallbladder Clinical trials for semaglutide did not exclude patients with prior cholecystectomy, and no major safety signals have emerged in post-market surveillance linking semaglutide use to worse outcomes in gallbladder-free patients
[2] Intravenous Glutathione: A Separate Consideration Patients receiving high-dose IV glutathione infusions (doses of 600 to 2,400 mg) for skin-lightening, chronic fatigue, or functional medicine protocols may reach transiently higher plasma glutathione concentrations than oral supplementation produces
Biochemical and Biophysical Research Communications
Neurobiol Dis 38:259265 de Paula S, Vitola AS, Greggio S, de Paula D, Mello PB, Lubianca JM, Xavier LL, Fiori HH, Dacosta JC (2009) Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells